SCHWCharles Schwab Corporation

During the three months ended September 30, 2026, certain of our directors and officers adopted or terminated trading arrangements for the sale of shares of our common stock as follows: Plans Action Date Rule 10b5-1 (1) Non-Rule 10b5-1 (2) Number of Securities to be Sold Latest Expiration (3) Jonathan S. Beatty, Managing Director and Head of Advisor Services Adoption 8/28/2026 x — 6,894 3/1/2027 (1) Intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). (2) Not intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). (3) The plan expires at the close of trading on the date presented or at such earlier date upon the completion of all trades under the plan (or the expiration of the orders relating to such trades without execution).

Securities to be sold under the plan represent the aggregate of (i) up to 93,972 shares of our common stock to be acquired upon the exercise of stock options; and (ii) the net after-tax number of shares of our common stock to be issued upon the settlement of PBRSUs vesting on March 1, 2026, which is based on the achievement of pre-established performance goals, and is not yet determinable. The actual number of shares that will be issued to the officer in connection with the unvested PBRSUs and sold under the trading arrangement will be net of the number of shares withheld to satisfy tax withholding obligations arising from the vesting of such PBRSUs.

Securities to be sold under the plan represent the aggregate of (i) up to 41,898 shares of our common stock to be acquired upon the exercise of stock options; and (ii) the net after-tax number of shares of our common stock to be issued upon the settlement of PBRSUs vesting on March 1, 2026, which is based on the achievement of pre-established performance goals, and is not yet determinable. The actual number of shares that will be issued to the officer in connection with the unvested PBRSUs and sold under the trading arrangement will be net of the number of shares withheld to satisfy tax withholding obligations arising from the vesting of such PBRSUs.

Securities to be sold under the plan represent the aggregate of (i) up to 139,948 shares of our common stock to be acquired upon the exercise of stock options; and (ii) the net after-tax number of shares of our common stock to be issued upon the settlement of performance-based restricted stock units (PBRSUs) vesting on March 1, 2026, which is based on the achievement of pre-established performance goals, and is not yet determinable. The actual number of shares that will be issued to the officer in connection with the unvested PBRSUs and sold under the trading arrangement will be net of the number of shares withheld to satisfy tax withholding obligations arising from the vesting of such PBRSUs.

During the three months ended September 30, 2024, certain of our directors and officers adopted or terminated trading arrangements for the sale of shares of our common stock as follows: Plans Action Date Rule 10b5-1 (1) Non-Rule 10b5-1 (2) Number of Securities to be Sold Latest Expiration (3) Carrie Schwab-Pomerantz, Director Adoption 8/14/2024 x — 240,000 (4) 10/16/2025 (1) Intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). (2) Not intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). (3) Plans expire at the close of trading on the date presented or at such earlier date upon the completion of all trades under the plan (or the expiration of the orders relating to such trades without execution). (4) Includes 96,000 shares to be sold by a trust for which the director’s spouse is a trustee.

During the three months ended March 31, 2024, certain of our directors and officers adopted or terminated trading arrangements for the sale of shares of our common stock as follows: Plans Action Date Rule 10b5-1 (1) Non-Rule 10b5-1 (2) Number of Securities to be Sold (3) Latest Expiration (4) Bernard J. Clark, Managing Director and Head of Advisor Services Adoption 2/27/2024 x — 3/17/2025 (1) Intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). (2) Not intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). (3) Securities to be sold under the plan represent the aggregate of (i) up to 81,085 shares of our common stock to be acquired upon the exercise of stock options; (ii) up to 48,761 shares of our common stock issued upon the settlement of performance-based restricted stock units (PBRSUs) that vested on March 1, 2024; and (iii) the net after-tax number of shares of our common stock to be issued upon settlement of PBRSUs vesting on March 1, 2025, which is based on the achievement of pre-established performance goals and is not yet determinable. The actual number of shares that will be issued to the officer in connection with the unvested PBRSUs and sold under the trading arrangement will be net of the number of shares withheld to satisfy tax withholding obligations arising from the vesting of such PBRSUs. (4) The plan expires at the close of trading on the date presented or at such earlier date upon the completion of all trades under the plan (or the expiration of the orders relating to such trades without execution).

During the three months ended September 30, 2023, certain of our officers and directors adopted or terminated trading arrangements for the sale of shares of our common stock as follows: Plans Action Date Rule 10b5-1 (1) Non-Rule 10b5-1 (2) Number of Securities to be Sold (3) Latest Expiration John K. Adams, Jr. , Director Adoption August 28, 2023 X — 15,701 Close of trading on May 15, 2025 (1) Intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). (2) Not intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). (3) Securities to be sold under the plan represent shares acquired upon the exercise of stock options.